Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Incidence of Non-Hodgkin Lymphoma in Iran: A Systematic Review and Meta-Analysis Publisher



Fouladseresht H1 ; Ghorbani M2 ; Hassanipour S3 ; Delam H1 ; Mokhtari AM4 ; Mohseni S5 ; Abdzadeh E6 ; Riahi S7 ; Mohammadianhafshejani A8 ; Salehiniya H9, 10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Public Health, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
  3. 3. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
  4. 4. Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Social Determinants in Health Promotion Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  6. 6. Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
  7. 7. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  8. 8. Department of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran
  9. 9. Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
  10. 10. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran

Source: World Cancer Research Journal Published:2019


Abstract

Objective: Non-Hodgkin’s lymphoma (NHL) is one of the common cancers of the blood. The present study is conducted to evaluate the incidence rates of NHL in Iran. Patients and Methods: A systematic search was conducted on all published studies of NHL incidence using Medline/PubMed, Scopus, Embase, Web of sciences, and four Iranian databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) until June 2018. This systematic review was done according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Results: After first searching 262 potentially relevant studies was yielded. A total of 9 studies were included. The results of the random effect model were demonstrated the age-standardized rate (ASR) of NHL was 4.43, 95% CI (2.76 to 6.11) among males and 2.79, 95% CI (1.71 to 3.88) among females. Conclusions: In comparison with other geographical locations, the incidence of NHL is lower in Iran. © 2019, Verduci International. All rights reserved.
Related Docs
View other Related Docs
1. The Incidence of Hepatocellular Carcinoma in Iran From 1996 to 2016: A Systematic Review and Meta-Analysis, Journal of Gastrointestinal Cancer (2019)
2. The Incidence of Laryngeal Cancer in Iran: A Systematic Review and Meta-Analysis, Clinical Epidemiology and Global Health (2019)
3. The Incidence of Bladder Cancer in Iran: A Systematic Review and Meta-Analysis, World Cancer Research Journal (2019)
4. The Incidence of Childhood Cancer in Iran: A Systematic Review and Meta-Analysis, Iranian Journal of Pediatric Hematology and Oncology (2019)
5. The Incidence of Kidney Cancer in Iran: A Systematic Review and Meta-Analysis, BioMedicine (France) (2018)
6. A Review of Incidence and Mortality of Colorectal, Lung, Liver, Thyroid, and Bladder Cancers in Iran and Compared to Other Countries, Wspolczesna Onkologia (2019)
7. Cancer Incidence in Iran in 2014: Results of the Iranian National Population-Based Cancer Registry, Cancer Epidemiology (2019)
8. The Incidence of Prostate Cancer in Iran: A Systematic Review and Meta-Analysis, Prostate International (2018)
Experts (# of related papers)
View all Related Experts
Reza Malekzadeh (4)
Hossein Poustchi (4)
Other Related Docs
9. Cancer Incidence in the East Azerbaijan Province of Iran in 2015-2016: Results of a Population-Based Cancer Registry, BMC Public Health (2018)
10. The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003–2008), International Journal of Preventive Medicine (2016)
11. Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article, Iranian Journal of Public Health (2018)
12. Diseases and Health Outcomes Registry Systems in I.R. Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research, Archives of Iranian Medicine (2017)
13. Incidence and Risk Factors of Colorectal Cancer in the Iranian Population: A Systematic Review, Journal of Gastrointestinal Cancer (2021)
14. Burden of Esophageal Cancer in Iran During 1995-2015: Review of Findings From the Global Burden of Disease Studies, Medical Journal of the Islamic Republic of Iran (2018)
15. The Leading Causes of Yll (Years of Life Lost) in the Province of Ghazvin and Comparison With Other Countries, Iran, Iranian Journal of Epidemiology (2015)
16. Pancreatic Cancer in Iran - Result of the Iranian National Cancer Registry Program, Asian Pacific Journal of Cancer Prevention (2022)
17. Evaluation of the Trends of Stomach Cancer Incidence in Districts of Iran From 2000-2010: Application of a Random Effects Markov Model, Asian Pacific Journal of Cancer Prevention (2016)
18. The Association of Dietary Quality Indices and Cancer Mortality: A Systematic Review and Meta-Analysis of Cohort Studies, Nutrition and Cancer (2018)
19. Association of Total Nut, Tree Nut, Peanut, and Peanut Butter Consumption With Cancer Incidence and Mortality: A Comprehensive Systematic Review and Dose-Response Meta-Analysis of Observational Studies, Advances in Nutrition (2021)
20. Geographical and Socioeconomic Inequalities in Female Breast Cancer Incidence and Mortality in Iran: A Bayesian Spatial Analysis of Registry Data, PLoS ONE (2021)
21. Spatial Analysis of Stomach Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
22. Building Cancer Registries in a Lower Resource Setting: The 10-Year Experience of Golestan, Northern Iran, Cancer Epidemiology (2018)
23. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
24. National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period, International Journal of Cancer Management (2023)
25. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)
26. Estimates of Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years of Lung Cancer in Iran, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, Cancer Medicine (2022)
27. Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures, Archives of Iranian Medicine (2021)
28. Environmental Etiology of Gastric Cancer in Iran: A Systematic Review Focusing on Drinking Water, Soil, Food, Radiation, and Geographical Conditions, Environmental Science and Pollution Research (2019)
29. Incidence and Trend of Liver Cancer in Iran, Journal of the College of Physicians and Surgeons Pakistan (2016)
30. Spatial Analysis of Breast Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
31. Source-Specific Lung Cancer Risk Assessment of Ambient Pm2.5-Bound Polycyclic Aromatic Hydrocarbons (Pahs) in Central Tehran, Environment International (2018)
32. Completeness and Underestimation of Cancer Mortality Rate in Iran: A Report From Fars Province in Southern Iran, Archives of Iranian Medicine (2015)
33. Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
34. A Comparison Between Accelerated Failure-Time and Cox Proportional Hazard Models in Analyzing the Survival of Gastric Cancer Patients, Iranian Journal of Public Health (2015)